Signicat Acquires UK-based Anti-Fraud and Identity Technology Company Sphonic
The combination with Sphonic will make the pan-European digital identity specialist better able to protect…
News
Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer
Former Abbott and Luminex executive with over 30 years of In Vitro Diagnostic (IVD) and…
ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases
The companies agree a follow-on collaboration to evaluate ViGeneron’s adeno-associated virus vectors (vgAAVs) for delivering…
Sosei Heptares to Embed Agile Operating Model and Enhance its Translational Medicine Capabilities through Strategic Collaboration with Weatherden
Key focus on enabling prioritization and rapid progression of pipeline programs through to clinical proof-of-concept,…
Active Biotech strengthens the patent protection for laquinimod in eye disorders
Lund, April 26, 2022, Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the European Patent…
APEIRON shareholders approve new group structure geared towards enabling innovation and growth
invIOs becomes fully separate entity focused on advancing its unique EPiC cell therapy platform and…
Valneva Announces Upsized Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed
Up to an additional $40 million made available as part of the agreement Saint–Herblain (France),…
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
Strong immunogenicity profile observed in study participants aged 5-17 years one month after the primary…
Idorsia announces financial results for the first quarter 2022 – first product launched, second in the starting blocks
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – April 26, 2022 Idorsia…
Novartis delivers solid sales and profit growth. Strong performance of in-market brands supports confidence in mid-term growth outlook
Ad hoc announcement pursuant to Art. 53 LR Q1 sales grew +5% (cc1, +1% USD),…
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the…
Dongfeng Honda to Begin Sales of All-new e:NS1 EV Model
BEIJING, China, Apr 26, 2022 – (JCN Newswire) – Honda Motor (China) Investment Co., Ltd.(HMCI),…
Seng Fong Holdings Berhad Obtains SC Approval for Main Market Listing
KUALA LUMPUR, Apr 26, 2022 – (ACN Newswire) – Seng Fong Holdings Berhad, a rubber…
Nkarta Announces Pricing of Upsized Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., April 25, 2022 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
Venturi Partners Hits Final Close of USD 175M in Maiden Fund
Singapore, Apr 26, 2022 – (ACN Newswire) – Venturi Partners, a Singapore-based investment platform that…
AFMG appoints Mr. Wilfried Porth as a non-executive director
HONG KONG, Apr 26, 2022 – (ACN Newswire) – Apollo Future Mobility Group Limited (“AFMG”,…
Correction: DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments
Montrouge, France, April 26, 2022DBV Technologies to Report First Quarter 2022 Financial Results and Recent…
Leeward Renewable Energy Operations Announces the Posting of Q4 2021 Financial Results and May 2 Investor Call
DALLAS–(BUSINESS WIRE)–Leeward Renewable Energy Operations, LLC (“LREO”) today announced that it has posted to its…
Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
DUBLIN, Ireland and CHICAGO, April 25, 2022 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update
Nearly $12 million in cash and investment Fully funded for the Company’s development programs, including…